Validation of a preclinical model for bone metastatic triple negative breast cancer

被引:0
|
作者
Zdrojewska, Justyna [1 ]
Suominen, Mari I. [1 ]
Fagerlund, Katja M. [1 ]
Halleen, Jussi M. [1 ]
Bernoulli, Jenni [1 ]
Zimmermann, Johann [2 ]
机构
[1] Pharmatest Serv, Turku, Finland
[2] Polyphor Ltd, Allschwil, Switzerland
关键词
D O I
10.1158/1538-7445.AM2019-2007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2007
引用
收藏
页数:2
相关论文
共 50 条
  • [2] Metastatic Triple-negative Breast Cancer
    Rakha, E. A.
    Chan, S.
    CLINICAL ONCOLOGY, 2011, 23 (09) : 587 - 600
  • [3] Metastatic Triple-Negative Breast Cancer
    Zhang, Xiaojie
    Yeung, Kay T.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (03) : 288 - 297
  • [4] Metastatic Triple-Negative Breast Cancer
    Xiaojie Zhang
    Kay T. Yeung
    Current Breast Cancer Reports, 2023, 15 : 288 - 297
  • [5] Differential efficacy of PD-1 targeted immunomodulation in preclinical models of primary and bone metastatic triple-negative breast cancer
    Kahkonen, Tiina E.
    Suominen, Mari I.
    Halleen, Jussi M.
    Haapaniemi, Teppo
    Tanaka, Azusa
    Seiler, Michael
    Bernoulli, Jenni
    CANCER RESEARCH, 2018, 78 (13)
  • [6] A new triple negative breast cancer (TNBC) murine model for in vivo preclinical immunotherapies
    Ferrucci, Veronica
    Pennino, Francesco Paolo
    Dassi, Luisa
    Asadzadeh, Fatemeh
    Siciliano, Roberto
    Carotenuto, Marianeve
    Spano, Daniela
    Chiarolla, Cristina Maria
    Greco, Adelaide
    Cantile, Monica
    Di Bonito, Maurizio
    Botti, Gerardo
    Jonathan, Vandenbussche
    Kris, Gevaert
    Zollo, Massimo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [7] Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression
    Arroyo-Crespo, Juan J.
    Armifian, Ana
    Charbonnier, David
    Deladriere, Coralie
    Palomino-Schatzlein, Martina
    Lamas-Domingo, Ruben
    Forteza, Jeronimo
    Pinedalucena, Antonio
    Vicent, Maria J.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (08) : 2267 - 2281
  • [8] Is Capecitabine Efficacious in Triple Negative Metastatic Breast Cancer?
    Kotsori, A. A.
    Dolly, S.
    Sheri, A.
    Parton, M.
    Shaunak, N.
    Ashley, S.
    Walsh, G.
    Johnston, S.
    Smith, I. E.
    ONCOLOGY, 2010, 79 (5-6) : 331 - 336
  • [9] Aggressive Subsets of Metastatic Triple Negative Breast Cancer
    Singh, Jasneet
    Asad, Sarah
    Zhang, Yiqing
    Nock, William
    Adams, Elizabeth
    Damicis, Adrienne
    Ramaswamy, Bhuvaneswari
    Williams, Nicole
    Parsons, Heather A.
    Adalsteinsson, Viktor A.
    Winer, Eric P.
    Lin, Nancy U.
    Partridge, Ann H.
    Overmoyer, Beth
    Stover, Daniel G.
    CLINICAL BREAST CANCER, 2020, 20 (01) : E20 - E26
  • [10] Atezolizumab for metastatic triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (10): : E519 - E519